Michael Landa, who has been deputy director of regulatory affairs at CFSAN since 2004, has agreed to serve as acting director. Roberta Wagner and Donald Kraemer will serve as acting deputy directors, said Food and Drug Administration (FDA) commissioner Margaret Hamburg and deputy commissioner Michael Taylor in a letter issued on Monday.
Michael Landa began his career with the FDA in 1978 as assistant chief counsel for Enforcement, Medical Devices and Veterinary Medicine.